|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
ATNX
|
Athenex, Inc.
|
US
|
NASDAQ
|
|
BHC
|
Bausch Health Companies Inc.
|
US
|
NYSE
|
|
CCXI
|
ChemoCentryx, Inc.
|
US
|
NASDAQ
|
|
EDSA
|
Edesa Biotech, Inc.
|
US
|
NASDAQ
|
|
FBRX
|
Forte Biosciences, Inc.
|
US
|
NASDAQ
|
|
HOTH
|
Hoth Therapeutics, Inc.
|
US
|
NASDAQ
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VYNE
|
VYNE Therapeutics Inc.
|
US
|
NASDAQ
|
|
ALIF
|
Artificial Life Inc
|
US
|
OTC
|
|
AVCRF
|
Avricore Health Inc.
|
US
|
OTC
|
|
BXPHF
|
Botanix Pharmaceuticals Ltd
|
US
|
OTC
|
|
CRRTF
|
Crescita Therapeutics Inc.
|
US
|
OTC
|
|
DVHGF
|
Devonian Health Group Inc
|
US
|
OTC
|
|
GLPGF
|
Galapagos Genomics Ord
|
US
|
OTC
|
|
LBTSF
|
Almirall Sa Ord
|
US
|
OTC
|
|
NXSCF
|
Next Science Ltd
|
US
|
OTC
|
|
PCYN
|
Procyon Corp New
|
US
|
OTC
|
|
PVCT
|
Provectus Pharma
|
US
|
OTC
|